DrugDev Celebrates 2016 Clinical Trials Day with the Unveiling of its New Site Perspectives Video Wall
Members of the 80,000+ person, 115-country DrugDev Investigator Network offer advice in short, compelling videos on how pharma can improve the clinical trials process and do more trials
King of Prussia, PA – As the pharma community celebrates 2016 Clinical Trials Day, DrugDev is launching the DrugDev Site Perspectives Video Wall, a new forum for clinical trial site professionals to give sponsors, CROs and technology vendors concrete advice and insights on how to improve the clinical trial process.
DrugDev President and CEO Ibs Mahmood, a member of The Medicine Maker’s 2016 Power 100, explained, “Investigators and site staff are the shared essential resource upon which we all rely, and we are driven to create technology solutions that return them to the heart of the industry. Sharing information among sponsors, CROs, sites and technology vendors will transform the cost and effectiveness of clinical trials so pharma can push far more medicines through the development process faster. The DrugDev Video Wall gives site staff – the front lines of clinical research with their patients – a way to inform the industry on exactly what their clinical trial experiences are like and how we can all work together to make it easier for them as they provide this essential service.”
Investigators and site staff from the global community discuss the joys and challenges of participating in clinical trials. Examples include:
Dr. Dimitar Gorgiev, CEO of Parafax Sciences in Sofia, Bulgaria, says he gets joy from clinical trials because he can bring patients something new. The biggest challenge is the paperwork, which can be tremendous.
Dr. Klitsunova Luliia Alexandrovna of the Zaporizhzhya Regional Clinical Hospital in Zaporizhzhya Oblast, Ukraine enjoys her work in clinical trials because she can take an active part in the administration of new drugs for patients. She says a challenge is finding the right patients for trials.
Dr.Georgios Dimopoulous of Attikon University Hospital in Athens, Greece, says there are three joys of working in clinical trials – research, collaboration with colleagues, and the financial support. He says if you asked 100 doctors around the world what is their biggest challenge in working on clinical trials they would say the tremendous amount of paperwork, signatures and administrative issues.
Dr. Jeffrey B. Rosen Medical Director and Founder of Clinical Research of South Florida, and Medical Director and founder of Community Medical Research in Miami, enjoys being on the cutting edge of science and seeing new medicines come to fruition. Dr. Rosen would like to see technology that saves time for both the patient and physicians. He feels the greatest challenge of clinical trials is that Investigators are not consulted in the development of protocols, and he says sites want to feel part of the process not like a commodity.
You can watch these and other videos here: DrugDev Site Perspectives Video Wall
DrugDev’s roots are in connecting investigators with sponsors/CROs. DrugDev Founder and President of SiteStart Melissa “Liss” Easy said, “The DrugDev Site Perspectives Video Wall is an enjoyable way for sites in our global network to appear alongside their colleagues among the world’s top investigators and site staff, and have their views heard by global heads of pharma.”
Members of the DrugDev Network can volunteer to post videos to the Video Wall by emailing email@example.com. In the three-minute videos investigators and site staff answer questions about what gives them joy in working in clinical research and what challenges they face in running clinical trials.
DrugDev’s unified clinical suite enables sponsors, CROs and sites to do more trials through industry-wide collaboration, standardization and a beautiful technology experience. Featuring solutions for global site payments, site identification and activation, workflow optimization, learning management, and site and patient engagement, DrugDev helps companies transform the quality and efficiency of clinical trials from startup through closeout. The company also powers the revolutionary TransCelerate Investigator Registry and Investigator Databank collaborations with the universal identifier known as the DrugDev Golden Number. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs trust DrugDev technology at drugdev.com.